Tentt

QliniQ Acquired by Marksans Pharma | Healthcare M&A Deal

Announced
HealthcareAdd-on

Deal Overview

Marksans Pharma has acquired QliniQ, a healthcare services other business in the Netherlands, for $7.5m. QliniQ B.V. provides healthcare services and supports delivery of medical care across the EU market from its Dutch base. Marksans Pharma acquisitions aim to strengthen EU reach through a healthcare services other acquisition and broaden service capabilities in the Netherlands. This strategic acquisition is structured as an add on acquisition, with Marksans Pharma as a strategic buyer pursuing healthcare M&A under $10m; deal status is announced and terms are not disclosed.

Key Details

Transaction
Marksans Pharma acquires QliniQ
Deal Size
Under $10M

Filed under

Source

Read full article on scanx.trade

via GN - signed definitive agreement · June 1, 2026

Powered by Tentt

Source healthcare deals for your firm

Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.

Book a 30-min intro call

Related Deals

See all Healthcare deals →